Controlled evaluation of a new topical corticosteroid in psoriasis.
D000085:Acetates / Q000627:therapeutic use; D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D005260:Female; D005446:Fluocinolone Acetonide / Q000627:therapeutic use*; D006801:Humans; D006854:Hydrocortisone; D008297:Male; D008875:Middle Aged; D009824:Ointments / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy*; D013997:Time Factors
D000085:Acetates; D000893:Anti-Inflammatory Agents; D009824:Ointments; D005446:Fluocinolone Acetonide; D006854:Hydrocortisone